國立高雄大學圖資館 |

Language: English

Back

Reviews on biomarker studies in psyc...

Guest, Paul C.

Reviews on biomarker studies in psychiatric and neurodegenerative disordersSpringer International Publishing :

Record Type:	Electronic resources : Monograph/item
Title/Author:	Reviews on biomarker studies in psychiatric and neurodegenerative disordersedited by Paul C. Guest.260
Reminder of title:	Springer International Publishing :
other author:	Guest, Paul C.
Description:	xiii, 328 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Biochemical markers.
Online resource:	https://doi.org/10.1007/978-3-030-05542-4
ISBN:	9783030055424$q(electronic bk.)

Reviews on biomarker studies in psychiatric and neurodegenerative disordersSpringer International Publishing :
Reviews on biomarker studies in psychiatric and neurodegenerative disordersSpringer International Publishing :[electronic resource] /edited by Paul C. Guest.260 - xiii, 328 p. :ill., digital ;24 cm. - Proteomics, metabolomics, interactomics and systems biology ;1118. - Proteomics, metabolomics, interactomics and systems biology ;1118..

1. The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans -- 2. The Role of Biomarkers in Alzheimer's Disease Drug Development -- 3. Mitochondrial Involvement in Mental Disorders; Energy Metabolism, Genetic and Environmental Factors -- 4. Lymphocytes, Platelets, Erythrocytes and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis -- 5. Genetic Risk Factors for Alzheimer Disease: Emerging Roles of Microglia in Disease Pathomechanisms -- 6. Neuroimaging Studies of Cognitive Function in Schizophrenia -- 7. The Role of Biomarkers in Psychiatry -- 8. Interactome Studies of Psychiatric Disorders -- 9. MicroRNAs in Major Depressive Disorder -- 10. Proteomic Markers for Depression -- 11. Advances in Biomarker Studies in Autism Spectrum Disorders -- 12. Proteomic Investigations of Autism Spectrum Disorder: Past Findings, Current Challenges and Future Prospects -- 13. Role of the Gut Microbiome in Autism Spectrum Disorders -- 14. Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia -- 15. Early Detection and Treatment of Patients with Alzheimer's Disease: Future Perspectives.

This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome.

ISBN: 9783030055424$q(electronic bk.)

Standard No.: 10.1007/978-3-030-05542-4doiSubjects--Topical Terms:

195446
Biochemical markers.

LC Class. No.: R853.B54 / R485 2019

Dewey Class. No.: 610.28

Reviews on biomarker studies in psychiatric and neurodegenerative disordersSpringer International Publishing :
LDR:03299nmm a2200325 a 4500 001 553530
003 DE-He213
005 20190827110931.0
006 m d
007 cr nn 008maaau
008 191112s2019 gw s 0 eng d
020 $a 9783030055424$q(electronic bk.)
020 $a 9783030055417$q(paper)
024 7 $a 10.1007/978-3-030-05542-4 $2 doi
035 $a 978-3-030-05542-4
040 $a GP $c GP
041 0 $a eng
050 4 $a R853.B54 $b R485 2019
072 7 $a PSA $2 bicssc
072 7 $a SCI086000 $2 bisacsh
072 7 $a PSA $2 thema
082 0 4 $a 610.28 $2 23
090 $a R853.B54 $b R454 2019
245 0 0 $a Reviews on biomarker studies in psychiatric and neurodegenerative disorders $h [electronic resource] / $c edited by Paul C. Guest.260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xiii, 328 p. : $b ill., digital ; $c 24 cm.
490 1 $a Proteomics, metabolomics, interactomics and systems biology ; $v 1118
505 0 $a 1. The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans -- 2. The Role of Biomarkers in Alzheimer's Disease Drug Development -- 3. Mitochondrial Involvement in Mental Disorders; Energy Metabolism, Genetic and Environmental Factors -- 4. Lymphocytes, Platelets, Erythrocytes and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis -- 5. Genetic Risk Factors for Alzheimer Disease: Emerging Roles of Microglia in Disease Pathomechanisms -- 6. Neuroimaging Studies of Cognitive Function in Schizophrenia -- 7. The Role of Biomarkers in Psychiatry -- 8. Interactome Studies of Psychiatric Disorders -- 9. MicroRNAs in Major Depressive Disorder -- 10. Proteomic Markers for Depression -- 11. Advances in Biomarker Studies in Autism Spectrum Disorders -- 12. Proteomic Investigations of Autism Spectrum Disorder: Past Findings, Current Challenges and Future Prospects -- 13. Role of the Gut Microbiome in Autism Spectrum Disorders -- 14. Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia -- 15. Early Detection and Treatment of Patients with Alzheimer's Disease: Future Perspectives.
520 $a This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome.
650 0 $a Biochemical markers. $3 195446
650 0 $a Nervous system $x Degeneration. $3 195201
650 0 $a Mental illness. $3 179814
650 1 4 $a Systems Biology. $3 245824
650 2 4 $a Proteomics. $3 220403
650 2 4 $a Gene Expression. $3 220379
700 1 $a Guest, Paul C. $3 771821
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Proteomics, metabolomics, interactomics and systems biology ; $v 1118. $3 834894
856 4 0 $u https://doi.org/10.1007/978-3-030-05542-4
950 $a Biomedical and Life Sciences (Springer-11642)